A Response to New Yorker Article on Long COVID

A person with ME (who wishes to remain anonymous online) sent this letter to the author of The New Yorker article, “The Struggle to Define Long COVID,” and to the magazine’s editor.

#MEAction was also concerned to see The New Yorker publish such a disparaging and flawed article about the Long COVID community, which cherry-picked examples of patient involvement while ignoring the incredible patient-led research the community has done to accelerate and strengthen research into Long COVID.

10/2/21

Dr. Khullar:

I am writing to you directly about your recent article on Long Covid with the hope you will take my comments to heart. I will copy The New Yorker as well.

It is clear that you are a compassionate person, struggling to understand a true conundrum. That said, I think your article was facile in many ways and reflects a dated and ill-informed understanding of post-infectious disease.

1. To start, before I comment on your treatment of Berrent, let me say that I do not know Berrent and did not hear of her before your article. My first complaint is that you treat Diana Berrent and her most fervent supporters/followers as the spokesperson/people for all those suffering from Long Covid. I think that is presumptuous and speculative. Further, some of your criticisms of her…and the conclusions you draw – seem unwarranted and exaggerated. Assuming for the sake of argument (and I actually agree with you here) that some of the ailments she views as symptomatic of Long Covid are far-fetched, you use that as a reason to dismiss commonly accepted Long Covid symptoms and imply primarily psychogenic causation. You also ignore that some of her critiques, like CDC’s decision not to investigate non-severe Long Covid cases, were also voiced by many medical/public health professionals. Similarly, you criticize her for her view of “mild” Covid cases. Yes, she is wrong to say that there are no mild cases. But it’s also true that the public –  having no reason to know better – interpreted “mild” in the dictionary sense – whereas the medical establishment considers “mild” anything that is not severe, i.e, resulting in hospitalization or death. Medical “mild” can still make one quite ill. Further, even asymptomatic and layperson’s “mild” cases cause Long Covid.

2. You seem dismissive of the validity of a “syndrome” or illness until research has established the cause or found a diagnostic test. Surely you know that serious illnesses such as MS and ulcers were once considered to be psychogenic in origin. And that post-infection sequelae have followed many past viral outbreaks. Instead, you choose to highlight Jeremy Devine’s view that Long Covid “is largely an invention of vocal patient activist groups” rather than talking to Long Covid experts/researchers. This is reminiscent of those who dismissed ME/CFS* as psychogenic. You don’t seem prepared to acknowledge that people can have diseases such as chronic fatigue syndrome, merely referring to “people who say they suffer from chronic fatigue syndrome….. Have you read the 2015 National Institute of Medicine Report on chronic fatigue syndrome or looked at the CDC/NIH websites on the disease? You characterize such diseases by saying “some researchers consider [them] ill-defined,” in a way that dismisses them rather than reflecting years of research neglect. Fortunately, there has been a lot of progress recently. Here’s just one article that was recently published in PNAS, both about ME/CFS and Long Covid. https://www.pnas.org/content/118/34/e2024358118 

3. Try talking to Avindra Nath, M.D, the Clinical Director of NINDS, the Director of the Translational Neuroscience Center, and Chief of the Section of Infections of the Nervous System, who is leading research on ME/CFS and Long Covid. Or Cornell’s own Mauren Hanson,  Director for the Center for Enervating Neuroimmune Disease. Or Ian Lipkin at Columbia. I doubt any of them would say Long Covid “lives for the moment in the realm of theory and anecdote.”  Your choice of interviewees was unbalanced.

4. You might have deduced that I am writing with some connection to Long Covid. Luckily, I have not had Covid. But I have had ME/CFS for 21 years. Consequently, I am all too aware of the medical establishment not having taken ME/CFS seriously. The ME/CFS community is, in fact, very distrusting of the medical community because patients often have not been treated with respect or understanding, and research into diagnosis, causation and treatment was at a standstill for decades. Thankfully, there has been a major turnaround in scientific understanding in recent years. But, based on the ME/CFS experience,  I fear the views that you stated or implied about Long Covid, and the leaps you took in reaching conclusions, pose a  greater problem than what some Long Covid advocates may have gotten wrong. I feel that you knew what you wanted to say and cherry-picked to support your conclusions. Please do your homework next time.

Respectfully,

* Please also note that federal agencies, numerous clinical guidance providers, and people afflicted by the disease now use the term myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) instead of chronic fatigue syndrome.

Facebook
Twitter
WhatsApp
Email

1 thought on “A Response to New Yorker Article on Long COVID”

Comments are closed.

Latest News

black square image with two white lines at the top and bottom of the image. Then another two white lines come out from the sides to the middle over the #MEAction logo and the words, #NotJustFatigue Video Series Elizabeth Ansell Interview.

#NotJustFatigue Video Series: Interview with Creator Elizabeth Ansell

Over the past year, the #NotJustFatigue website, created by Elizabeth Ansell, releases a 10-part, documentary style, short form video series on different aspects involved in living with ME. Titles of the videos include topics such as: You Have No Idea How Serious This Is, Nobody Believes ME, and It’s Not Hysteria: It’s Sexism. In these

Read More »
navy blue square. there are two white lines at the top and bottom of the square. The #MEAction logo in at the top of the image. The words #MEAction Georgia Voice of the Patient in coordination with the Center for Disease Control and Prevention & Emory School of Nursing.

#MEAction Georgia: Voice of the Patient in Coordination with CDC & Emory School on Nursing

Back in September, #MEAction Georgia State Chapter partnered with the Centers for Disease Control and Prevention (CDC) and Emory School of Nursing to host, Voice of the Patient: A Panel Discussion with #MEAction Georgia. This event was a continuation of #MEAction Georgia’s #MillionsMissing 2024: #TeachMETreatME programming. Erin Lee and Liz Burlingame of the #MEAction Georgia

Read More »
a light blue square image with medical instruments/tools as a border (pill bottles, scales, needles, covid protein spike, etc). At the top of the image is the Home Test to Treat Program logo, in blue font: Findings Summary. Below that the #MEAction logo and Body Politic Logo.

Home Test To Treat – Findings Summary

#MEAction and Body Politic collaborated last spring, with a new national telehealth program, Home Test to Treat. We are now able to share initial findings from the program! Here are some highlights: 80K + enrolled in the program across the country! 40K + test distributed 6K + individuals treated for COVID-19 or flu 5.6K+ organizations

Read More »
Scroll to Top